Micro needling and exsynutriment in the treatment of Telogen Effluvium
PDF (Português (Brasil))

Keywords

Queda de Cabelo
Alopecia
Succinato de desvenlafaxina
Antidepressivo
Calvice

How to Cite

1.
Raies SC, Brandão BJF. Micro needling and exsynutriment in the treatment of Telogen Effluvium. bwsj [Internet]. 2021 Dec. 16 [cited 2025 Oct. 16];4:1-7. Available from: https://bwsjournal.emnuvens.com.br/bwsj/article/view/184

Abstract

Telogen effluvium was first described by Kligman in 1961. It is a most common cause of diffuse hair loss. Women with telogen effluvium more frequently present to dermatologist. A wide variety of potential triggers have been implicated in the pathogenesis of telogen effluvium. Diffuse shedding of telogen hair are seen after 3-4 months of triggering event. The observation of increased telogen hair shedding does not infer a cause. Establishing aetiology of telogen effluvium requires elicitation of relevant history and appropriate laboratory investigations to exclude endocrine, nutritional and autoimmune disorders.

 

PDF (Português (Brasil))
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Copyright (c) 2021 Sarah Cestari Raies; Byron José Figueiredo Brandão (Orientador)